SCHEMBL13065611

SCHEMBL13065611

CNc1ccc2nc3c(C(=O)O)c(-c4ccc(C(=O)O)cc4)c(=O)c(O)c-3oc2c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 1/20 0.39
NPC1 O15118 3/20 0.36
RAB9A P51151 3/20 0.36
TTR P02766 1/20 0.36
ALB P02768 1/20 0.36
MAOA P21397 1/20 0.36
CNR1 P21554 1/20 0.36
DRD1 P21728 1/20 0.36
OPRD1 P41143 1/20 0.36
PDE4D Q08499 1/20 0.36
PDE3A Q14432 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
CSNK2A2 P19784 2/20 0.36
CSNK2B P67870 2/20 0.36
CSNK2A1 P68400 2/20 0.36
CSNK2A3 Q8NEV1 2/20 0.36
CASP3 P42574 1/20 0.35
SENP8 Q96LD8 1/20 0.35
SENP7 Q9BQF6 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13065589 0.91 DHODH (0.40) NPC1RAB9AMEN1KMT2ACASP3
SCHEMBL16784715 0.90 TP53 (0.42) MAOAMEN1KMT2ACSNK2A2CSNK2B
SCHEMBL13065615 0.89 HPSE (0.37) NPC1RAB9APDE4DMEN1KMT2A
SCHEMBL13065738 0.82 HPGD (0.42) NPC1RAB9AMEN1KMT2ACSNK2A2
SCHEMBL13065605 0.82 MEN1 (0.43) GPR119NPC1RAB9ATTRALB
SCHEMBL13065590 0.78 MAPT (0.38) NPC1RAB9AMEN1KMT2ACASP3
SCHEMBL13065612 0.77 CNR1 (0.36) GPR119NPC1RAB9ACNR1MEN1
SCHEMBL16784717 0.77 DHODH (0.39) GPR119NPC1RAB9AMEN1KMT2A
SCHEMBL13065731 0.75 DHODH (0.47) NPC1RAB9AMAOAOPRD1MEN1
SCHEMBL13065735 0.75 LMNA (0.48) NPC1RAB9AMEN1KMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9052324-B2 Compounds and assays for controlling Wnt activity ENZO BIOCHEM, INC. (US) 2015-06-09 US disclosed
US-20120322717-A9 Compounds and assays for controlling Wnt activity ENZO BIOCHEM, INC. 2012-12-20 US disclosed
US-20100298200-A1 Compounds and assays for controlling Wnt activity LIU DAKAI 2010-11-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120322717-A9 Compounds and assays for controlling Wnt activity WNT1, WNT3A, WNT3 GPR119 4018/4885NPC1 2196/4885RAB9A 2459/4885
US-20100298200-A1 Compounds and assays for controlling Wnt activity WNT1, WNT3A, WNT3 GPR119 4018/4885NPC1 2196/4885RAB9A 2459/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.